OncoMed Pharmaceuticals Inc. President and CEO Paul Hastings will resume his role as board chairman, effective Dec. 4.
Hastings has been on medical leave since September.
The office of the president — comprising John Lewicki, executive vice president of research and development, and Executive Vice President and CFO Sunil Patel — will continue to perform the duties of the president and CEO.
